Caribou Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Caribou Biosciences (CRBU).

Price Target Range — 11 Quarters

Analyst Consensus — 10 Analysts

5Buy

5Hold

Consensus RatingBuy# Analysts10Avg. Consensus PT$9Upside to Avg. PT+1783.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 8, 2026	HC Wainwright & Co.	Robert Burns	Downgrade	Buy→Neutral	—
Oct 7, 2026	Brookline Capital	Leah Cann	Downgrade	Buy→Hold	—
Oct 7, 2026	RBC Capital	Luca Issi	Downgrade	Outperform→Sector Perform	$10→$1
Oct 7, 2026	Leerink Partners	Daina Graybosch	Downgrade	Outperform→Market Perform	$4→$1
Aug 14, 2026	B of A Securities	Alec Stranahan	PT Cut	Buy	$6→$5
May 11, 2026	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$9→$11
Apr 7, 2026	HC Wainwright & Co.	Robert Burns	Maintained	Buy	$9
Mar 9, 2026	Evercore ISI Group	Jonathan Miller	PT Raise	Outperform	$11→$13
Feb 2, 2026	Clear Street	Bill Maughan	Initiate	Buy	$13
Nov 5, 2025	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$3→$9
Nov 3, 2025	Citigroup	Yigal Nochomovitz	PT Raise	Buy	$5→$8
Apr 28, 2025	HC Wainwright & Co.	Robert Burns	PT Cut	Buy	$9→$3
Mar 19, 2025	HC Wainwright & Co.	Robert Burns	Maintained	Buy	$9
Jan 7, 2025	B of A Securities	Alec Stranahan	PT Cut	Buy	$13→$11
Nov 26, 2024	Citigroup	Yigal Nochomovitz	PT Cut	Buy	$30→$6
Nov 15, 2024	HC Wainwright & Co.	Robert Burns	Maintained	Buy	$9
Sep 3, 2024	HC Wainwright & Co.	Robert Burns	Maintained	Buy	$9
Aug 14, 2024	HC Wainwright & Co.	Robert Burns	Maintained	Buy	$9
Aug 7, 2024	RBC Capital	Luca Issi	Maintained	Outperform	$14
Jul 17, 2024	HC Wainwright & Co.	Robert Burns	Maintained	Buy	$9

Analyst Ratings News

This Voya Financial Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Analysts downgraded Voya, Pacira, Genworth, and more, with price-target changes for several.

Avi Kapoor

This Tyler Technologies Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Analysts downgraded STZ, TYL, DK, CRBU and PSX; price targets changed for STZ, TYL, DK and PSX.

Avi Kapoor

PRO
HC Wainwright & Co. Downgrades Caribou Biosciences to Neutral

HC Wainwright & Co. analyst Robert Burns downgrades Caribou Biosciences (NASDAQ:CRBU) from Buy to Neutral.

Benzinga Newsdesk

This Option Care Health Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday

Analysts downgraded PJT, OPCH, CRBU, ABEV , cutting price targets for PJT, CRBU.

Avi Kapoor

PRO
Brookline Capital Downgrades Caribou Biosciences to Hold

Brookline Capital analyst Leah Cann downgrades Caribou Biosciences (NASDAQ:CRBU) from Buy to Hold.

Benzinga Newsdesk

PRO
RBC Capital Downgrades Caribou Biosciences to Sector Perform, Lowers Price Target to $1

RBC Capital analyst Luca Issi downgrades Caribou Biosciences (NASDAQ:CRBU) from Outperform to Sector Perform and lowers the price target from $10 to $1.

Benzinga Newsdesk

Caribou Biosciences Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Caribou Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Voya Financial Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

This Tyler Technologies Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

PRO
HC Wainwright & Co. Downgrades Caribou Biosciences to Neutral

This Option Care Health Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday

PRO
Brookline Capital Downgrades Caribou Biosciences to Hold

PRO
RBC Capital Downgrades Caribou Biosciences to Sector Perform, Lowers Price Target to $1

People Also Watch

People Also Watch

Caribou Biosciences Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Caribou Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Voya Financial Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

This Tyler Technologies Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

PROHC Wainwright & Co. Downgrades Caribou Biosciences to Neutral

This Option Care Health Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday

PROBrookline Capital Downgrades Caribou Biosciences to Hold

PRORBC Capital Downgrades Caribou Biosciences to Sector Perform, Lowers Price Target to $1

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Downgrades Caribou Biosciences to Neutral

PRO
Brookline Capital Downgrades Caribou Biosciences to Hold

PRO
RBC Capital Downgrades Caribou Biosciences to Sector Perform, Lowers Price Target to $1